Powered by Advanced and Clinically Tested Bioprinting Technologies
PrintBio is deploying technologies utilized to manufacture and implant the first 3D-bioprinted living tissues in patients.  PrintBio is the only clinical-stage regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants. Leveraging first in human clinical experience, PrintBio is developing an array of products, beginning with 3DMatrix™, a 3D-printed monofilament bioresorbable surgical mesh (pending 510(k) FDA approval), utilizing its proprietary technologies clinically tested in patients.

PrintBio, Inc.

Org chart

Teams

Offices